Trial Profile
Comparison of the bacterial microbiota in the skin and gut of psoriasis patients before and after sytemic treatment with adalimumab and ustekinumab or cyclosporin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Ciclosporin (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms MIPSO
- 29 May 2018 New trial record